ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
41.03
0.49%
US Tech 100
21,474.80
0.18%
S&P 500
6,115.07
1.04%
US Dollar vs CAD
1.41628
-0.21%
Bitcoin
97,055.06
0.45%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Dyne Therapeutics Inc (DYN)

  7. Dyne Therapeutics Inc (DYN) News

DYN

Dyne Therapeutics (DYN)

Dyne Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DYN
DateTimeSourceHeadlineSymbolCompany
02/03/20256:30AMGlobeNewswire Inc.Dyne Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences ConferenceNASDAQ:DYNDyne Therapeutics Inc
01/21/20256:30AMGlobeNewswire Inc.Dyne Therapeutics Receives FDA Fast Track Designation for DYNE-101 for the Treatment of Myotonic Dystrophy Type 1NASDAQ:DYNDyne Therapeutics Inc
01/10/20255:56AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DYNDyne Therapeutics Inc
01/10/20255:30AMGlobeNewswire Inc.Dyne Therapeutics Reports New Clinical Data Showing Compelling Impact on Multiple Measures of Myotonic Dystrophy Type 1 (DM1); Dyne Plans to Initiate Registrational Expansion Cohort to Support Potential Submission for U.S. Accelerated Approval for DYNE-101NASDAQ:DYNDyne Therapeutics Inc
01/09/20256:30AMGlobeNewswire Inc.Dyne Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:DYNDyne Therapeutics Inc
01/08/20253:05PMGlobeNewswire Inc.Dyne Therapeutics to Host Investor Conference Call and Webcast to Review New Clinical Data from the ACHIEVE Trial Friday, January 10 at 8:00 a.m. ETNASDAQ:DYNDyne Therapeutics Inc
12/11/20247:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
12/11/20243:19PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DYNDyne Therapeutics Inc
12/10/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
12/06/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
12/06/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
12/06/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
12/04/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
11/25/20243:11PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DYNDyne Therapeutics Inc
11/22/20243:06PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DYNDyne Therapeutics Inc
11/18/20246:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
11/18/20243:40PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DYNDyne Therapeutics Inc
11/18/20243:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
11/18/20243:13PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DYNDyne Therapeutics Inc
11/18/20243:06PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DYNDyne Therapeutics Inc
11/18/20243:05PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DYNDyne Therapeutics Inc
11/15/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
11/14/20243:59PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DYNDyne Therapeutics Inc
11/14/20248:27AMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:DYNDyne Therapeutics Inc
11/14/20246:00AMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:DYNDyne Therapeutics Inc
11/12/20248:20AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DYNDyne Therapeutics Inc
11/12/20246:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DYNDyne Therapeutics Inc
11/12/20246:30AMGlobeNewswire Inc.Dyne Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:DYNDyne Therapeutics Inc
11/08/20244:31PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:DYNDyne Therapeutics Inc
11/07/20243:15PMGlobeNewswire Inc.Dyne Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:DYNDyne Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:DYN

Your Recent History

USOTC
IDVV
International Endeavors (PK)
USOTC
MONI
Moon Equity (PK)
USOTC
GVSI
Good Vibrations Shoes (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
NASDAQ
MGOL
MGO Global
USOTC
AZRH
Azure (PK)
NASDAQ
LWLG
Lightwave Logic
NASDAQ
IDCC
InterDigital
USOTC
ASII
Accredited Solutions (PK)
USOTC
CLNV
Clean Vision (QB)
USOTC
TGLO
TheGlobe com (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
PDGO
Paradigm Oil and Gas (PK)
COIN
XRPUSD
Ripple
NASDAQ
AMRN
Amarin
USOTC
SPZI
Spooz (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads